Clinical Trial Update: Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of SHR-1918 in patients with Homozygous Familial Hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• SHR-1918

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Homozygous Familial Hypercholesterolemia | Phase 2 | Status: COMPLETED